Protective Effects of Glucose-Related Protein 78 and 94 on Cisplatin-Mediated Ototoxicity
Cisplatin is a widely used chemotherapeutic drug for treating various solid tumors. Ototoxicity is a major dose-limiting side effect of cisplatin, which causes progressive and irreversible sensorineural hearing loss. Here, we examined the protective effects of glucose-related protein (GRP) 78 and 94...
Main Authors: | Junyeong Yi, Tae Su Kim, Jhang Ho Pak, Jong Woo Chung |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/9/8/686 |
Similar Items
-
Physiological Roles of the Autoantibodies to the 78-Kilodalton Glucose-Regulated Protein (GRP78) in Cancer and Autoimmune Diseases
by: Mario Gonzalez-Gronow, et al.
Published: (2022-05-01) -
New role of endoplasmic reticulum chaperones in regulating metaplasia during tumorigenesis
by: Jieli Shen, et al.
Published: (2017-11-01) -
Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review
by: Amos Olalekan Akinyemi, et al.
Published: (2023-08-01) -
Scratching the Surface—An Overview of the Roles of Cell Surface GRP78 in Cancer
by: Jack Chen, et al.
Published: (2022-05-01) -
Genetically Engineered Hepatitis C Virus-like Particles (HCV-LPs) Tagged with SP94 Peptide to Acquire Selectivity to Liver Cancer Cells via Grp78
by: Dina Mofed, et al.
Published: (2022-08-01)